MedTrace Logo

Post Marketing Surveillance for Contac Bien Z in Japan

NCT02020902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1552

Last updated 2016-05-16

No results posted yet for this study

Summary

This is a post-marketing surveillance study on a marketed cetrizine hydrochloride formulation.

Conditions

  • Allergic Rhinitis
  • Seasonal Allergic Rhinitis

Interventions

OTHER

Cetrizine hydrochloride

As provided on the patient information leaflet

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02020902 on ClinicalTrials.gov